|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sleeman J and Steeg PS: Cancer metastasis
as a therapeutic target. Eur J Cancer. 46:1177–1180. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arya M, Bott RS, Shergill IS, Ahmed HU,
Williamson M and Patel HR: The metastatic cascade in prostate
cancer. Surg Oncol. 15:117–128. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fraser SP, Ding Y, Liu A, Foster CS and
Djamgoz MB: Tetrodotoxin suppresses morphological enhancement of
the metastatic MAT-LyLu rat prostate cancer cell line. Cell Tissue
Res. 295:505–512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fraser SP, Salvador V, Manning EA, Mizal
J, Altun S, Raza M, Berridge RJ and Djamgoz MB: Contribution of
functional voltage-gated Na+ channel expression to cell behaviors
involved in the metastatic cascade in rat prostate cancer: I.
Lateral motility. J Cell Physiol. 195:479–487. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Djamgoz MBA, Mycielska M, Madeja Z, Fraser
SP and Korohoda W: Directional movement of rat prostate cancer
cells in direct-current electric field: Involvement of
voltage-gated Na+ channel activity. J Cell Sci. 114:2697–2705.
2001.PubMed/NCBI
|
|
7
|
Grimes JA, Fraser SP, Stephens GJ, Downing
JE, Laniado ME, Foster CS, Abel PD and Djamgoz MB: Differential
expression of voltage-activated Na+ currents in two prostatic
tumour cell lines: Contribution to invasiveness in vitro. FEBS
Lett. 369:290–294. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laniado ME, Lalani EN, Fraser SP, Grimes
JA, Bhangal G, Djamgoz MB and Abel PD: Expression and functional
analysis of voltage-activated Na+ channels in human prostate cancer
cell lines and their contribution to invasion in vitro. Am J
Pathol. 150:1213–1221. 1997.PubMed/NCBI
|
|
9
|
Smith P, Rhodes NP, Shortland AP, Fraser
SP, Djamgoz MB, Ke Y and Foster CS: Sodium channel protein
expression enhances the invasiveness of rat and human prostate
cancer cells. FEBS Lett. 423:19–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abdul M and Hoosein N: Voltage-gated
sodium ion channels in prostate cancer: Expression and activity.
Anticancer Res. 22:1727–1730. 2002.PubMed/NCBI
|
|
11
|
Bennett ES, Smith BA and Harper JM:
Voltage-gated Na+ channels confer invasive properties on human
prostate cancer cells. Pflugers Arch. 447:908–914. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yildirim S, Altun S, Gumushan H, Patel A
and Djamgoz MB: Voltage-gated sodium channel activity promotes
prostate cancer metastasis in vivo. Cancer Lett. 323:58–61. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cestèle S and Catterall WA: Molecular
mechanisms of neurotoxin action on voltage-gated sodium channels.
Biochimie. 82:883–892. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ritchie CK, Andrews LR, Thomas KG, Tindall
DJ and Fitzpatrick LA: The effects of growth factors associated
with osteoblasts on prostate carcinoma proliferation and
chemotaxis: Implications for the development of metastatic disease.
Endocrinology. 138:1145–1150. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bedir E, Kırmızıpekmez H, Sticher O and
Caliş I: Triterpene saponins from the fruits of Hedera helix.
Phytochemistry. 53:905–909. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Demirci B, Goppel M, Demirci F and Franz
G: HPLC profiling and quantification of active principles in leaves
of Hedera helix L. Pharmazie. 59:770–774. 2004.PubMed/NCBI
|
|
17
|
Danloy S, QuetinLeclercq J, Coucke P, De
Pauw-Gillet MC, Elias R, Balansard G, Angenot L and Bassleer R:
Effects of alpha-hederin, a saponin extracted from Hedera helix, on
cells cultured in vitro. Planta Med. 60:45–49. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barthomeuf C, Debiton E, Mshvildadze V,
Kemertelidze E and Balansard G: In vitro activity of
hederacolchisid A1 compared with other saponins from Hedera
colchica against proliferation of human carcinoma and melanoma
cells. Planta Med. 68:672–675. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cioacá C, Margineanu C and Cucu V: The
saponins of Hedera helix with antibacterial activity. Pharmazie.
33:609–610. 1978.
|
|
20
|
MoulinTraffort J, Favel A, Elias R and
Regli P: Study of the action of α-hederin on the ultrastructure of
Candida albicans. Mycoses. 41:411–416. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Julien J, Gasquet M, Maillard C, Balansard
G and Timon-David P: Extracts of the ivy plant, Hedera helix, and
their antihelminthic activity on liver flukes. Planta Med.
3:205–208. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
MajesterSavornin B, Elias R, DiazLanza AM,
Balansard G, Gasquet M and Delmas F: Saponins of the ivy plant,
Hedera helix, and their leishmanicidic activity. Planta Med.
57:260–262. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Facino MR, Carini M, Stefani R, Aldini G
and Saibene L: Anti-elastase and anti-hyaluronidase activities of
saponins and sapogenins from Hedera helix, Aesculus hippocastanum,
and Ruscus aculeatus: Factors contributing to their efficacy in the
treatment of venous insufficiency. Arch Pharm (Weinheim).
328:720–724. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
deMedeiros JM, Macedo M, Contancia JP,
Nguyen C, Cunningham G and Miles DH: Antithrombin activity of
medicinal plants of the Azores. J Ethnopharmacol. 72:157–165. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tennant TR, Kim H, Sokoloff M and
Rinker-Schaeffer CW: The Dunning model. Prostate. 43:295–302. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bancroft JD and Stevens A: Proteins and
nucleic acidsTheory and Practice of Histological Techniques. 3rd
edition. Churchill Livingstone; Edinburgh, UK: pp. 148–188.
1990
|
|
27
|
Fraser SP, Grimes JA and Djamgoz MB:
Effects of voltage-gated ion channel modulators on rat protastic
cancer cell proliferation: Comprarison of strongly and weakly
metastic cell lines. Prostate. 44:61–76. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bun SS, Elias R, Baghdikian B, Ciccolini
J, Ollivier E and Balansard G: Alpha-hederin potentiates 5-FU
antitumor activity in human colon adenocarcinoma cells. Phytother
Res. 22:1299–1302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park HJ, Kwon SH, Lee JH, Lee KH, Miyamoto
KI and Lee KT: Kalopanaxsaponin A is a basic saponin structure for
the anti-tumor activity of hederagenin monodesmosides. Planta Med.
67:118–121. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Swamy SM and Huat BT: Intracellular
glutathione depletion and reactive oxygen species generation are
important in alpha-hederin-induced apoptosis of P388 cells. Mol
Cell Biochem. 245:127–139. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
StetlerStevenson WG, Aznavoorian S and
Liotta LA: Tumor cell interactions with the extracellular matrix
during invasion and metastasis. Annu Rev Cell Dev Biol. 9:541–573.
1993. View Article : Google Scholar
|
|
32
|
Isaacs JT, Isaacs WB, Feitz WF and Scheres
J: Establishment and characterization of seven Dunning rat
prostatic cancer cell lines and their use in developing methods for
predicting metastatic abilities of prostatic cancers. Prostate.
9:261–281. 1986. View Article : Google Scholar : PubMed/NCBI
|
